Refoxy Pharmaceuticals
Latest round
- Seed
Last raised
- Jul 2024
Total raised
- $9.9M
Investors
- 5
About Refoxy Pharmaceuticals
Based in Cologne, Germany, and founded in 2020 by co-founder Dr. Victor Bustos (CEO) and Prof. Wolfgang Link, Refoxy Pharmaceuticals GmbH operates as a provider of therapeutics leveraging the FOXO3 transcription factor to address idiopathic pulmonary fibrosis and other fibrotic and cardiovascular conditions for healthcare systems in North America and Europe.Venture, and High-Tech Grunderfonds. Refoxy Pharmaceuticals specializes in discovering and developing advanced therapeutics aimed at the FOXO3 transcription factor. Their primary offerings include small molecule activators tailored to treat age-related conditions, including idiopathic pulmonary fibrosis (IPF) and various fibrotic and cardiovascular diseases.act finder platform, Refoxy conducts phenotypic screenings to identify effective FOXO3 activators, targeting primarily the North American and European markets, where such conditions are prevalent. Refoxy Pharmaceuticals generates income through strategic partnerships with pharmaceutical companies, often structured around licensing agreements for its FOXO3 activators.
Who invested in Refoxy Pharmaceuticals
5 investors across 1 round
See all investors in Refoxy Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 31, 2024
Amount
$9.9M
Investors
Questions about Refoxy Pharmaceuticals
Who invested in Refoxy Pharmaceuticals?
Refoxy Pharmaceuticals has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Refoxy Pharmaceuticals raised?
Refoxy Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Refoxy Pharmaceuticals last raise money?
Refoxy Pharmaceuticals's most recent round on record is a Seed, in Jul 2024.
What does Refoxy Pharmaceuticals do?
Based in Cologne, Germany, and founded in 2020 by co-founder Dr.
Where is Refoxy Pharmaceuticals headquartered?
Refoxy Pharmaceuticals is headquartered in Cologne, Germany.
Which VCs invest in companies like Refoxy Pharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Refoxy Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Refoxy Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.